Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women

Incretin Based Therapies: Bone Protective Effects

(2014) Marlene Chakhtoura et al.   Endocrine Metabolic & Immune Disorders-Drug Targets

Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin

(2013) María José Tolosa et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats

(2013) Xue Ma et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing

(2013) J. Jeyabalan et al.   OSTEOPOROSIS INTERNATIONAL

Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line

(2013) M. Salai et al.   Bone & Joint Journal

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets

(2012) P. Marchetti et al.   DIABETOLOGIA

The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice

(2012) Chun Wang et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Bone, sweet bone—osteoporotic fractures in diabetes mellitus

(2012) Christine Hamann et al.   Nature Reviews Endocrinology

Incretin-based therapies - review of the physiology, pharmacology and emerging clinical experience

(2011) J. H. Martin et al.   INTERNAL MEDICINE JOURNAL

AICAR, a Small Chemical Molecule, Primes Osteogenic Differentiation of Adult Mesenchymal Stem Cells

(2011) Wei Wu et al.   INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats

(2011) Qi-Guang Mai et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Effects of vildagliptin on postprandial markers of bone resorption and calcium homeostasis in recently diagnosed, well-controlled type 2 diabetes patients*

(2011) Mathijs C. BUNCK et al.   Journal of Diabetes

AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass

(2010) M. Shah et al.   BONE

Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2

(2010) Won Gu Jang et al.   BONE

Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats

(2010) Ying Gao et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States

(2009) Bernardo Nuche-Berenguer et al.   CALCIFIED TISSUE INTERNATIONAL

Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies

(2009) M Silvina Molinuevo et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoblast differentiation is functionally associated with decreased AMP kinase activity

(2009) Takayuki Kasai et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Metformin reverses the deleterious effects of high glucose on osteoblast function

(2009) Donghu Zhen et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Incretin-based therapies for type 2 diabetes mellitus

(2009) Julie A. Lovshin et al.   Nature Reviews Endocrinology

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression

(2008) Ippei Kanazawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS